not happy, page-10

Hi Kym
To put the Cantrixil toxicology results on the company website and not accompany with an explained announcement to the markets is extraordinary at the least. Why? I have sent many emails to you regarding my concerns with the lack of markets announcements where one is warranted.
The broader market has no idea what Novogen are up to and this morning 4% in MC drop on such a huge milestone, from my interpretation of the Toxicology results, to clinical trials is upsetting at the least. Isn’t this at least worthy of notifying the ASX.???
Or are these non disclosure patterns to the wider market, noticed in the last 10 months, have a wider motive.??
If there is no motive can shareholders and interested investors have access to a “layman terms” (Market announcement) of the toxicology report and what this means to the company moving forward.
Cheers

Not happy Jan at all!!!!!
Novogen are in aposition to project themselves into clinical trials with one of many exciting platforms and the Marketing and PR depts are missing in action.!!!
How long dose a simple Power Point presso take to explain the results and where this leaves Novogen's scope and vision moving forward into 2016?
Yep...not happy!!